How health policies impact women with autoimmune diseases during pregnancy
Effects of health policy on the health of people with systemic autoimmune and rheumatic diseases
This study is looking at how health policies affect women with autoimmune and rheumatic diseases during pregnancy, aiming to understand their experiences and access to care, so we can better support their health and treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11167103 on NIH RePORTER |
What this research studies
This research investigates the effects of health policies on women with systemic autoimmune and rheumatic diseases (SARDs), particularly during their reproductive years and pregnancy. It aims to understand how these policies influence access to healthcare, treatment quality, and health outcomes for pregnant individuals with SARDs. The study will involve interviews with patients and rheumatologists to gather insights on their experiences and decision-making processes, as well as analysis of national claims data to assess broader trends. By focusing on the intersection of health policy and reproductive health, this research seeks to highlight the unique challenges faced by this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are women of reproductive age who have been diagnosed with systemic autoimmune and rheumatic diseases and are either pregnant or planning to become pregnant.
Not a fit: Patients who do not have systemic autoimmune or rheumatic diseases or who are not of reproductive age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance the health outcomes of women with autoimmune diseases during pregnancy.
How similar studies have performed: While there has been some research on the health outcomes of women with SARDs, this specific focus on health policy's impact is relatively novel and has not been extensively studied.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Talabi, Mehret Birru — University of Pittsburgh at Pittsburgh
- Study coordinator: Talabi, Mehret Birru
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.